drugset / Trial / NCT00223496
12- Week Open Label Treatment of Refractory Bipolar Depression
Phase 4
Completed
32 enrolled
The University of Texas Health Science Center at San Antonio
Bristol-Myers Squibb · collab
NaSingle-groupOpen-labelTreatment
Summary
1. Determine the change in symptomatology and function in refractory bipolar depression, when treated with combination of DEP+AZP for a period of 12 weeks 2. Determine the tolerability and safety of AZP added to DEP in the treatment of refractory bipolar depression
Timeline
- Start
- 2004-09
- Primary completion
- 2009-09
- Completion
- 2009-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aripiprazole | Other / unclassified | 5 mg | — |
| Subject | Aripiprazole | Other / unclassified | 30 mg | — |